BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26594035)

  • 1. Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.
    Drummond FJ; O'Leary E; Gavin A; Kinnear H; Sharp L
    Support Care Cancer; 2016 May; 24(5):2297-2307. PubMed ID: 26594035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.
    Sharp L; O'Leary E; Kinnear H; Gavin A; Drummond FJ
    Psychooncology; 2016 Mar; 25(3):282-91. PubMed ID: 26249170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.
    Drummond FJ; Kinnear H; Donnelly C; O'Leary E; O'Brien K; Burns RM; Gavin A; Sharp L
    BMJ Open; 2015 Apr; 5(4):e006851. PubMed ID: 25888474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.
    Flahavan EM; Drummond FJ; Bennett K; Barron TI; Sharp L
    BMC Fam Pract; 2014 Jun; 15():121. PubMed ID: 24938184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample.
    Kotwal AA; Schumm P; Mohile SG; Dale W
    Med Care; 2012 Dec; 50(12):1037-44. PubMed ID: 22955835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
    Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
    BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
    Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
    J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
    Baden M; Lu L; Drummond FJ; Gavin A; Sharp L
    Support Care Cancer; 2020 Oct; 28(10):4813-4824. PubMed ID: 31980895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.
    Kobayashi M; Nukui A; Kamai T
    Int J Clin Oncol; 2017 Feb; 22(1):174-180. PubMed ID: 27631094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.
    Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P
    BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6months after diagnosis.
    Boyes AW; Girgis A; D'Este C; Zucca AC
    J Affect Disord; 2011 Dec; 135(1-3):184-92. PubMed ID: 21864913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
    Donnelly DW; Vis LC; Kearney T; Sharp L; Bennett D; Wilding S; Downing A; Wright P; Watson E; Wagland R; Cross WR; Mason MD; Siesling S; van Manen JG; Glaser AW; Gavin A
    BMC Cancer; 2019 Oct; 19(1):947. PubMed ID: 31615476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey.
    Boyes AW; Girgis A; Zucca AC; Lecathelinais C
    Med J Aust; 2009 Apr; 190(S7):S94-8. PubMed ID: 19351302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer.
    Sharp L; Carsin AE; Timmons A
    Psychooncology; 2013 Apr; 22(4):745-55. PubMed ID: 22411485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study.
    Karlsen RV; Larsen SB; Christensen J; Brasso K; Friis S; Tjønneland A; Dalton SO
    Acta Oncol; 2013 Nov; 52(8):1609-14. PubMed ID: 23978293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.